Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come
- PMID: 9217633
- DOI: 10.1016/s0002-9343(97)00032-6
Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come
Abstract
An oral fluid-based test for antibodies to human immunodeficiency virus (HIV), equivalent to serum in its accuracy but safer and easier to use, is now available in the United States. The development of the oral test involved overcoming technical obstacles to the use of oral fluid as a testing medium, including low immunoglobulin G (IgG) titers, suboptimal assay performance, protease degradation of IgG, high viscosity, and lack of a standardized method of specimen collection, all of which contribute to suboptimal assay performance. The currently available oral HIV test utilizes a collection device to isolate a mucosal transudate component of oral fluid rich in IgG. A vial containing a preservative solution facilitates the transport of stable, low-viscosity specimens to the laboratory for testing with an ELISA and confirmatory Western blot assay, specifically designed for use with oral fluid. Non-HIV medical conditions and oral pathologies do not appear to affect oral test results. Hopefully, the availability of a more patient-friendly, portable diagnostic test for antibodies to HIV will facilitate identification of greater numbers of infected individuals with the ultimate goals of early identification, early treatment, and prevention of disease transmission.
Similar articles
-
Accuracy of oral specimen testing for human immunodeficiency virus.Am J Med. 1997 Apr 1;102(4A):15-20. doi: 10.1016/s0002-9343(97)00033-8. Am J Med. 1997. PMID: 9217634 Review.
-
Future applications of oral fluid specimen technology.Am J Med. 1997 Apr 1;102(4A):21-5. doi: 10.1016/s0002-9343(97)00034-x. Am J Med. 1997. PMID: 9217635
-
Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. OraSure HIV Clinical Trials Group.JAMA. 1997 Jan 15;277(3):254-8. JAMA. 1997. PMID: 9005276 Clinical Trial.
-
A modified ELISA and western blot accurately determine anti-human immunodeficiency virus type 1 antibodies in oral fluids obtained with a special collecting device.J Infect Dis. 1995 Jun;171(6):1406-10. doi: 10.1093/infdis/171.6.1406. J Infect Dis. 1995. PMID: 7769274
-
Detecting viruses by using salivary diagnostics.J Am Dent Assoc. 2012 Oct;143(10 Suppl):12S-8S. doi: 10.14219/jada.archive.2012.0338. J Am Dent Assoc. 2012. PMID: 23034833 Free PMC article. Review.
Cited by
-
Salivary C-reactive protein-a possible predictor of serum levels in pediatric acute respiratory illness.Eur J Pediatr. 2021 Aug;180(8):2465-2472. doi: 10.1007/s00431-021-04047-6. Epub 2021 Apr 6. Eur J Pediatr. 2021. PMID: 33822246
-
Ability of salivary biomarkers in the prognostic of systemic and buccal inflammation.J Clin Exp Dent. 2017 May 1;9(5):e716-e722. doi: 10.4317/jced.53776. eCollection 2017 May. J Clin Exp Dent. 2017. PMID: 28512552 Free PMC article. Review.
-
Need for an Ethical Framework for Testing for Systemic Diseases in Dental Clinics.Ethics Biol Eng Med. 2011 Apr 1;2(2):115-136. doi: 10.1615/EthicsBiologyEngMed.2012004545. Ethics Biol Eng Med. 2011. PMID: 24600534 Free PMC article.
-
Enzyme-linked immunosorbent assay using recombinant SAG1 antigen to detect Toxoplasma gondii-specific immunoglobulin G antibodies in human sera and saliva.Clin Vaccine Immunol. 2013 Apr;20(4):468-73. doi: 10.1128/CVI.00512-12. Epub 2013 Jan 23. Clin Vaccine Immunol. 2013. PMID: 23345586 Free PMC article.
-
Salivary biomarker development using genomic, proteomic and metabolomic approaches.Genome Med. 2012 Oct 30;4(10):82. doi: 10.1186/gm383. eCollection 2012. Genome Med. 2012. PMID: 23114182 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical